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Objective: Lymphopenia is a predictor of adverse clinical outcomes in adults with various systemic diseases. We
hypothesized that preoperative absolute lymphopenia (absolute lymphocyte count of less than 3000 cells/mL) is
associated with adverse postoperative outcomes in children with congenital heart disease undergoing corrective
or palliative surgery on cardiopulmonary bypass during the first 2 years of life.
Methods:A retrospective single center cohort study was performed. Categorical variables were analyzed with the
c2 test. Preoperative variables were analyzed with logistic and linear regression analysis to determine whether
they were associated with adverse outcomes.
Results: Analysis was performed on 280 patients, of whom 124 were female and 156 were male. Seventy-one
patients were neonates (30 days) at the time of the operation. Ninety patients had an absolute lymphocyte count
of less than 3000 cells/mL before the operation. Regression models showed that RACHS-1 categories 5 and 6, age,
and preoperative lymphopenia were significantly associated with postoperative mortality (P< .0006). Within
RACHS-1 groups, lymphopenia remained a significant predictor of mortality for patients in RACHS categories
3 and 4. Lymphopenia and age were associated with longer length of stay and length of mechanical ventilation
within RACHS categories 1 to 4 (P< .05). Preoperative lymphopenia was the only predictor of use of postop-
erative nitric oxide (P< .05).
Conclusions: Preoperative lymphopenia is a predictor of adverse postoperative outcomes in children with con-
genital heart disease who undergo a corrective or palliative procedure with cardiopulmonary bypass during the
first 2 years of life.Lymphocytes play a central role in both innate and adaptive
immunity.1 A decrease in absolute lymphocyte count (ALC)
secondary to congenital or acquired immunodeficiency is as-
sociated with increased susceptibility to infections.2,3 Lym-
phocyte cell number and distribution are distinctly different
in children from values for adults. In adults, an ALC of less
than 1000 cells/mL is considered diagnostic of lymphope-
nia.4 By contrast, in children less than 2 years of age, an
ALC of 3000 cells/mL corresponds to the fifth percentile
of the ALC.4-7
A decrease in ALC has been reported in acutely and crit-
ically ill adult patients with systemic inflammatory response
syndrome8 and has also been noted in more chronic, stressful
conditions such as congestive heart failure in adult pa-
tients.9-11 Profound B lymphocyte and CD4 positive T cell
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immunosuppression seen in critically ill patients.12 Pro-
longed lymphopenia associated with critical illness can sig-
nificantly increase risk for nosocomial infections and
death.9-11,13
We observed that many patients in our pediatric cardio-
vascular intensive care unit had low ALCs preoperatively.
This trend was especially noticeable in neonates and infants
with complex congenital heart disease, who were frequently
noted to have ALCs below 3000 cells/mL. Bocsi and associ-
ates14 have demonstrated that in children with congenital
heart disease aged 3 to 18 years, the preoperative decrease
in lymphocyte percentage was one of the predictors of post-
operative edema and effusions. However, there are no pub-
lished studies assessing the risk of lymphopenia in younger
children with congenital heart disease.
We sought to determine whether preoperative absolute
lymphopenia (ALC< 3000 cells/mL) was an independent
predictor of adverse postoperative outcomes in children
less than 2 years of age undergoing surgery for complex con-
genital heart disease.
METHODS
Patients
We conducted a retrospective review of medical records of children
undergoing cardiac surgery at Arkansas Children’s Hospital from Januaryrgery c November 2009
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CI ¼ confidence interval
OR ¼ odds ratio
RACHS-1 ¼ Risk Adjusted classification for
Congenital Heart Surgery
ROC ¼ receiver operating characteristic
2003 to June 2005. The study protocol was approved by the Institutional Re-
view Board at the University of Arkansas for Medical Sciences and waiver
for obtaining informed consent was granted. We included all children less
than 2 years of age who were undergoing their first cardiac surgical proce-
dure with cardiopulmonary bypass and who had preoperative complete
blood count with differential available. We excluded children under 2 years
of age whowere undergoing procedures without cardiopulmonary bypass or
those undergoing orthotopic heart transplantation, inasmuch as heart trans-
plantation is not included the Risk Adjusted classification for Congenital
Heart Surgery (RACHS-1) used.
We identified 280 children who met the inclusion criteria and did not
meet the exclusion criteria. Data from these patients were extracted from
hospital chart, an electronic surgical database, and the laboratory data sys-
tem and were reviewed retrospectively.
Data Collection
Preoperative variables included patient’s age, sex, birth weight, cardiac
diagnoses including presence of chromosomal or structural anomalies, use
of preoperative inotropes, need for preoperative mechanical ventilation,
need for preoperative extracorporeal life support, preoperative laboratory
values obtained a day before the operation including complete blood count
with differential, serum albumin, blood urea nitrogen, and serum creatinine.
Low birth weight was defined as less than 2500 g. Intraoperative variables
included cardiopulmonary bypass time, crossclamp time, and RACHS-1
surgical procedure category.
TheRACHS-1method is a consensus-based risk adjustment classification
that assesses surgical complexity and organizes surgical procedures into 6
categories; relatively simple surgical procedures, such as repair of an atrial
septal defect, are assigned category 1 and complex operations, such as Nor-
wood palliation for hypoplastic left heart syndrome, are assigned the highest
risk category of 6. The RACHS-1 classification has been shown to reflect
mortality and length of stay in large pediatric heart surgery populations.15-17
Outcomes
The primary outcome measure was survival to hospital discharge for pa-
tients. Other postoperative outcomes studied were length of hospital stay,
length of mechanical ventilation, presence of renal dysfunction as defined
by the RIFLE criteria (Risk, Injury, Failure, Loss, End-stage kidney disease)
of a 50% increase in serum creatinine value,18 need for dialysis, use of nitric
oxide, use of extracorporeal life support, use of hydrocortisone for pressor-
resistant hypotension, duration of chest tube retention, use of low fat formula
as a surrogate for chylous effusion in the postoperativeperiod, level of positive
end-expiratory pressure and inotrope score on the first postoperative day, total
number of bacterial cultures (blood, urine, and respiratory) sent in the postop-
erative period, and number of positive cultures in the postoperative period.
Statistical Analysis
Our statistical analysis was aimed at studying the contribution of the pre-
operative variables on the primary and secondary outcomes noted above.
For the purposes of analysis, study subjects were assigned to one of two
groups on the basis of their preoperative ALC counts: group 1 patientsThe Journal of Thoracic and C(n ¼ 90) had an ALC of 3000 cells/mL or less and group 2 patients (n ¼
190) had an ALC of greater than 3000 cells/mL. On the basis of RACHS-
1 category, 3 levels of surgical risk were defined: low risk, RACHS-1 cat-
egories 1 and 2; medium risk, RACHS-1 categories 3 and 4; high risk,
RACHS-1 categories 5 and 6.
We performed an inverse square root transformation of age because the
relationship between age and mortality is complex in that mortality is in-
creased in the youngest infants, possibly as a result of the complexity of le-
sions and of the surgical interventions needed in the early neonatal period.19
All patients receiving inotropes in the postoperative study period were as-
signed an inotrope score based on a published reference.20 The following
variables were analyzed in a dichotomous manner: serum albumin, low or
normal based on the lower limit of the clinical laboratory’s reference range
(<2.6 gm/dL); serum creatinine and blood urea nitrogen, normal or high
based on the upper limit of the laboratory normal range (0.6 mg/dL and
18 mg/dL); and presence of a known genetic or chromosomal/genetic ab-
normality or a congenital abnormality not associated with known genetic
defect.
The c2 test, t test, or Wilcoxon rank sum test was used to test for differ-
ences in the preoperative variables and in the postoperative outcomes be-
tween the lymphopenic and nonlymphopenic patients. The univariate
logistic regression results are presented as odds ratios, favoring lympho-
penic or control with their 95% confidence interval (CI). Binary outcomes
were analyzed by multiple stepwise logistic regression analysis. All preop-
erative variables including transformed age, gender, RACHS-1 category
(low, 1-2; medium, 3-4, high, 6), presence or absence of genetic and/or con-
genital anomaly, presence of low birth weight (<2500 g), need for preop-
erative mechanical ventilation, inotrope score, presence of low serum
albumin level, high creatinine level, high blood urea nitrogen level, and
lymphopenia (ALC<3000 cells/mL) were included in the stepwise multi-
ple logistic regression models. The preoperative variables included in the
analysis are based on variables identified by Jenkins and associates16 as
significant clinical risk factors for mortality16 and preoperative variables
associated with increased postoperative length of stay.21,22 We added pre-
operative albumin inasmuch as we had observed before our study that most
of the patients who were lymphopenic also had low serum albumin concen-
trations. Coefficients were tested for significance for inclusion or elimina-
tion from the model using the Wald test or likelihood-ratio test. The
goodness of fit of the model fit using the stepwise procedure was assessed
by the Hosmer-Lemshow goodness-of-fit test. When included in the multi-
variable model with risk category, the single factor that provided the most
additional predictive information about mortality was retained in the model;
the remaining factors were then re-evaluated. The process was repeated un-
til none of the remaining factors contributed significantly to the prediction
of mortality.
For postoperative mortality, the area under the receiver operating charac-
teristic (ROC) curves was used to assess the discriminatory value of the
fitted logistic regression models. Cox proportional hazards models were
used to analyze the length of stay and length of mechanical ventilation
with censoring of patients who died at the time of death.
Data were entered in customized Access Database (Microsoft Corpora-
tion, Redmond, Wash) and analyzed with either SAS version 9 (SAS Insti-
tute, Inc, Cary, NC) or STATA version 10 (Stata Corporation, College
Station, Tex) statistical packages.
RESULTS
Baseline preoperative characteristics of the 2 groups are
outlined in Table 1. Stepwise logistic regression analysis
showed that group 1 patients were more likely to have low
preoperative albumin levels (odds ratio [OR] 2.3 with
95% CI 1.1-4.7), higher serum creatinine concentrations
(OR, 4.1; 95% CI, 2.1-8.4), presence of genetic orardiovascular Surgery c Volume 138, Number 5 1173
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Group 1 (ALC<3000); n ¼ 90 Group 2 (ALC>3000); n¼ 190 P value
Age at operation (mean days  SD) 165  203 208  184 .09
30 days (%) 43 17
31 days to 1 year (%) 40 63
1 to 2 years (%) 17 18
Male sex (%) 64 52 .04
White (%) 49 64 .017
African American (%) 42 26 .01
Chromosomal/genetic or congenital anomaly (%) 29 23 .37
Trisomy 21 57% 54%
DiGeorge syndrome 8% 2%
Turner syndrome 8% 0%
Noonan syndrome 4% 2%
Other genetic anomaly 4% 5%
Other congenital anomaly 19% 37%
Percent LBW 16% 6% .016
Albumin (g/dL, mean  SD) 3.2  0.6 3.7  0.6 <.0001
Creatinine (mg/dL, mean  SD) 0.5  0.2 0.4  0.1 .00036
Hematocrit (%,mean  SD) 40.6  6.6 38.3  5.6 .002
WBC count (cell/mm3, mean  SD) 8.7  4.3 10.6  3.6 .0004
Platelet count (mm3, mean  SD) 273.1  99.7 371.1  115.5 <.0001
Percent needing preoperative mechanical ventilation 21.70 12.40 .01
Inotrope score (mean  SD) 0.97  2.7 0.27  1.6 .024
RACHS-1 <.0001
No. in RACHS-1 category 1 (%) 0 (0) 6 (3)
No. in RACHS-1 category 2 (%) 26 (29) 105 (52)
No. in RACHS-1 category 3 (%) 33 (37) 54 (28)
No. in RACHS-1 category 4 (%) 19 (21) 16 (8)
No. in RACHS-1 category 6 (%) 12 (13) 9 (5)
ALC, Absolute lymphocyte count; LBW, Low birth weight (<2500 g); SD, standard deviation; WBC, white blood cell count; RACHS, Risk Adjusted classification for Congenital
Heart Surgery.congenital anomalies (OR, 2.1; 95% CI, 1.1-3.8), and
higher inotrope scores (OR 1.2 with 95% CI 1.1-1.5).
Postoperative outcomes are shown in Table 2. Stepwise
regression analysis showed that preoperative lymphopenia1174 The Journal of Thoracic and Cardiovascular Swas a predictor of postoperative mortality, length of hospital
stay, length of mechanical ventilation, and postoperative ni-
tric oxide use. It was not a predictor for the other outcomes
shown in Table 2.TABLE 2. Univariate analysis of postoperative outcomes
Postoperative outcome variables Group I (ALC<3000) Group 2 (ALC  3000)
Odds ratio for
lymphopenia with 95% CI P value
Percent hospital mortality 14.4 1.1 15.9 (3.5-72) .001
Median length of stay (95% CI) 17 (13-23) 7 (7-9) 1.0 (1.0-1.02) .02
Median length of mechanical
ventilation (95% CI)
4 (3-6.6) 2 (1-2) 1.0 (1.0-1.1) .001
Renal dysfunction (yes/no) (%) 65.2 64.6 1.0 (0.7-1.7) .92
Need for dialysis (yes/no) (%) 17.8 11.6 1.7 (0.8-3.3) .16
Postop ECLS (%) 12.2 3.7 3.6 (1.4-9.7) .01
Postop inhaled nitric oxide (%) 22.2 5.3 5.1 (2.9-11.5) .0001
Mean chest tube duration (d) 5.6  6.5 3.7  3.3 1.1 (1.0-1.2) .005
Hydrocortisone use in the postop period (%) 13.3 4.2 3.5 (1.4-8.9) .009
Chylous effusion in the postop period (%) 22.2 8.4 3.1 (1.5-6.3) .002
Level of PEEP on postop day 1 6.7  2 6.3  1.7 1.1 (0.98-1.3) .08
Inotrope score on postop day 1 13.1  10.7 9.4  6.5 1.1 (1.0-1.1) .002
Positive cultures (yes/no) (%) 35.6 27.0 1.5 (0.9-2.6) .14
Number of cultures sent 14  25 7  17 1.02 (1.0-1.03) .01
ALC, Absolute lymphocyte count; CI, confidence interval; ECLS, extracorporeal life support; PEEP, positive end-expiratory pressure.urgery c November 2009
Cabrera et al Congenital Heart DiseaseTABLE 3. Multivariable model for prediction of postoperative mortality from preoperative variables
Full model Stepwise fit
Odds ratio (95% CI) Wald P value Odds ratio (95% CI) Wald P value
Lymphopenia (ALC<3000 cells/mm3) 9.3 (1.8-48) .009 10.6 (2.3-50) .003
RACHS-1 medium-risk vs low-risk groups 3.7 (0.4-36.5) .339
RACHS-1 high-risk vs low-risk groups 17.1 (1.4-203.9) .082 4.2 (1.1-15.1) .031
Transformed age 1.1 (0.9-1.4) .043 1.2 (1-1.4) .011
Male gender 0.6 (0.2-2.3) .337
Need for preop mechanical ventilation 0.3 (0-1.7) .116
Presence of chromosomal/genetic congenital
anomaly (yes vs no)
1 (0.2-4.7) .707
Preoperative need for inotropes 1.2 (1-1.6) .191
Presence of low albumin (<2.6 g/dL) 2.3 (0.6-9.4) .637
High creatinine (>0.6 mg/dL) 1.2 (0.3-5.7) .696
High BUN (>18 mg/dL) 2.2 (0.3-16.2) .457
CI, Confidence interval; ALC, absolute lymphocyte count; RACHS, Risk Adjusted classification for Congenital Heart Surgery; BUN, blood urea nitrogen.C
H
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A multivariate model showed that patient’s age, presence
of lymphopenia, and high risk category were predictive of
mortality (see Table 3) in our patients with the area under
the ROC of 0.90. When data were analyzed within risk cat-
egories, lymphopenia was a statistically significant predictor
of mortality in medium risk patients. Althoughmortality was
also higher for lymphopenic patients undergoing low-risk
and high-risk procedures, the difference in mortality did
not achieve statistical significance (see Figure 1).
Length of Hospital Stay
Age at the time of the operation (P<.0001) and lympho-
penia (P< .0001) were significant predictors for length of
hospital stay in a multivariate analysis (Figure 2, A).The me-
dian length of stay was 17 days (CI, 13.23) for lymphopenic
patients and 7 days (CI, 7.9) for nonlymphopenic patients.
By 60 days only 2.2% of nonlymphopenic patients had
remained in the hospital compared with 14.87% in the lym-
phopenic group. When data were analyzed within risk cate-
gories, lymphopenic patients were consistently noted to
have longer lengths of stay (Figure 2, B). The presence of
lymphopenia and younger age at operation remained signif-
icant predictors of length of stay for low- and medium-risk
groups (P< .05), and lymphopenia almost reached signifi-
cance as a predictor for length of stay in the high-risk group
(P ¼ .08).
Effect on Respiratory Support
In a multivariate analysis, preoperative lymphopenia,
along with transformed age, risk category, and presence of
chromosomal or congenital anomaly, were predictive of
increased length of mechanical ventilation (P< .05) (see
Figure 3,A).When datawere analyzedwithin risk categories,
lymphopenic patients were consistently noted to have longer
duration ofmechanical ventilation (see Figure 3,B). Preoper-
ative lymphopenia and age at operation remained significantThe Journal of Thoracic and Cpredictors of duration of mechanical ventilation in low- and
medium-risk groups (P< .05).Preoperative lymphopenia
did not reach significance as a predictor of length of mechan-
ical ventilation in the high-risk group (P¼ .08). Preoperative
lymphopenia remained the only predictor of postoperative
use of nitric oxide (P< .05).
DISCUSSION
In this retrospective review of children undergoing
cardiac surgery before the age of 2 years, preoperative
lymphopenia was found to be an independent risk factor
for postoperative mortality, increased hospital stay, and
increased postoperative respiratory support including the
sole predictor of nitric oxide use. We chose to examine the
total number of cultures sent as a surrogate for febrile illness
in our patients. Although the univariate analysis showed an
increase in the total number of cultures sent in lymphopenic
patients, no statistical difference was noted in the proportion
of positive bacterial cultures. This could be explained by the
fact that lymphopenic patients are at risk for the develop-
ment of viral infections that would not have been detected
by routine bacterial or fungal cultures.
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FIGURE 1. Impact of lymphopenia on mortality within risk groups. The
P values by Fisher’s exact test were as follows: low-risk group, .19; the
medium-risk group, .005; and the high-risk group, .34.ardiovascular Surgery c Volume 138, Number 5 1175
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allow meaningful comparisons of in-hospital mortality for
children undergoing surgery for congenital heart disease16
that has been used to predict postoperative mortality (area
under the ROC between 0.74 and 0.78) and hospital
stay.15,17,19,23 The addition of age at operation has been
shown to increase the ability of RACHS-1 to predict mortal-
ity to an area under the ROC of 0.81.19 Our study confirmed
the above findings that younger age at operation and in-
creased surgical complexity are powerful preoperative pre-
dictors of postoperative mortality and that the addition of
lymphopenia to the model further enhances this predictive
ability with area under the ROC increasing to 0.90.
The causes of preoperative lymphopenia are likely multi-
factorial and broadly fall into 3 categories: increased de-
struction, decreased production, and lymphocyte loss
secondary to sequestration or drainage.
Lymphopenia, along with young age and male sex, has
been shown to be an important predictor of the need for ac-
tive emergency room resuscitation and admission to pediat-
ric intensive care units in infants less than 3 months of age.24
Stress response, manifested by elevated norepinephrine and
cortisol levels, is associated with lymphopenia.11 Profound
lymphopenia has also been recently associated with the sud-
den and rapid release of proinflammatory cytokines in
voluntary individuals after the intravenous infusion of
TGN1412, a novel superantagonist anti-CD28 monoclonal
antibody that directly stimulates T cells.8 This rapid deple-
tion is thought to be caused by apoptosis of both B and T
lymphocytes, and inhibition of this apoptosis by caspase
inhibitors has been proposed as a mechanism to enhance
immunity.25 It is possible that patients with more chronic
conditions, such as congestive heart failure, have a similar
increase in lymphocyte apoptosis in response to raised levels
of various inflammatory cytokines and chemokines.26 Defi-
ciencies in factors necessary for lymphocyte growth and pro-
liferation, such as zinc, may contribute to lymphopenia in
patients with prolonged marginal nutrition.27 Another cause
for lymphopenia in critically ill children may include use of
the inotropic agent dopamine, which is known to suppress
the production of prolactin, which is thought to play an im-
portant role in lymphocyte proliferation; its absence can
lower the ALC.28 In our study, the patients with preoperative
lymphopenia were more likely to be receiving higher doses
of dopamine and other catecholamines. The threshold for
lymphopenia-induced dopamine in critically ill patients
has not been determined.
Congenital heart disease and decreased T-lymphocyte
production secondary to thymic hypoplasia are seen together
FIGURE 2. A, Kaplan–Meier analysis of the association of length of stay
between patients with and without preoperative lymphopenia. B, Kaplan–
Meier analysis of the association of length of stay between patients with
and without preoperative lymphopenia within risk categories.urgery c November 2009
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deletions of 22q11 or 10p13).2 Infants with Down syndrome
are also thought to have a disturbance in their adaptive im-
munity inasmuch as they do not undergo the normal expan-
sion of T and B lymphocytes seen in children without Down
syndrome. Children with Down syndrome also have lower
absolute T and B cell counts until at least 15 months of
age, with some recovery in T cell population at older ages
but continued depression in B lymphocyte count.29 In our
study, lymphopenic patients were more likely to have
known congenital anomalies including DiGeorge and
Down syndromes.
Cardiac lesions associated with pulmonary venous ob-
struction, such as hypoplastic left heart syndrome or total
anomalous pulmonary venous return, are also known to be
associated with pulmonary lymphatic dysplasia.30-33 Sur-
gery and inflammatory conditions can lead to secondary lym-
phatic dysplasia also.34 Some genetic syndromes, such as
Turner syndrome, Noonan syndrome, LEOPARD syndrome
(Lentigines, Electrocardiogram abnormalities, Ocular hyper-
teleorism, Pulmonary stenosis, Abnormal genitalia, Retarda-
tion of growth, Deafness), or Costello syndrome, are also
associated with cardiac defects and lymphedema. Lymphe-
dema seen in these children is a reflection of the inadequacy
of the lymphatic system as a result of congenital lymphatic
dysplasia.34-36 The filtered plasma proteins, lipids, and lym-
phocytes that normally leak from the bloodstream into the
interstitium accumulate in the extracellular space as chyle.
Chyle is rich in lymphocytes, triglycerides, and proteins
including albumin and globulins.36 A larger proportion of
the lymphopenic patients in our studywere given low-fat for-
mulas in the postoperative period, suggesting the clinical
presence of chylous effusions. Although chylous effusions
can certainly occur as a consequence of damage to the lym-
phatics during surgery, the higher incidence in patients who
are lymphocytopenic preoperatively indicates that these
effusions are likely a result of existing lymphatic dysplasia.
The presence of pulmonary lymphangiectasia may explain
the need for prolonged mechanical ventilation with higher
settings and increased use of nitric oxide in our patients,
which in turn leads to increased length of hospital stay.
Several limitations of our study should be considered
while interpreting our results. The most complex congenital
heart lesions, such as hypoplastic left heart syndrome and
transposition of great arteries, are repaired in the early neo-
natal period to get the best outcomes. This leads to the
strong, but nonlinear, relationship seen between age and
high risk categories.19 We tried to minimize this selection
FIGURE 3. A, Kaplan–Meier analysis of the association of days on me-
chanical ventilation among patients with and without preoperative lympho-
penia. B, Kaplan–Meier analysis of the association of length of mechanical
ventilation between patients with and without preoperative lymphopenia
within risk categories.rdiovascular Surgery c Volume 138, Number 5 1177
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a persistent effect of lymphopenia on outcomes. The pres-
ence of confounding variables in retrospective studies is
a limitation. A stepwise logistic regression analysis showed
that lymphopenic subjects were more likely to have congen-
ital anomalies, higher preoperative inotrope scores, and
lower preoperative albumin and creatinine levels. We tried
to minimize the effect of the confounding variables by doing
a multivariate analysis and by analyzing the data within risk
categories also. The confounding preoperative variables
suggest possible etiologies discussed above because we
believe that lymphopenia is a sign, not the disease. We
did analyze the lymphocyte count as a continuous variable
in addition to the dichotomous analysis presented here
with no difference in results. However, we did note that
each drop in the ALC of 1000 cells/mm3 results in an in-
crease in the risk of mortality by 2.67-fold. We do not
know whether the decrease in lymphocytes is across all sub-
sets of lymphocytes or whether particular subsets are more
suppressed. Future studies are needed to investigate this in
more detail. The presence of a relatively small number of
patients in the RACHS-1 category 1 and absence of any
patients in the RACHS-1 category 5 group limited our abil-
ity to analyze the data; therefore, for the purposes of statis-
tical analysis, we consolidated the RACHS-1 risk categories
into the 3 groups (low-, medium-, and high-risk). The rarity
of the two procedures listed in category 5 (neonatal repair of
Ebstein anomaly and truncus arteriosus with interrupted
aortic arch) is a well-known limitation of the RACHS-1
risk stratification. Another limitation introduced by the use
of RACHS-1 was the exclusion of patients who underwent
cardiac transplantation. Nine patients, who otherwise met
the study inclusion criteria, underwent transplant during
the study period at our center but were not included in the
analysis.
In summary, the preoperative determination of lympho-
penia in critically ill children with congenital heart disease
is one of the predictors of postoperative death, need for
prolonged hospital stay, need for increased postoperative
respiratory support, and prolonged postoperative suppres-
sion of lymphocyte count. Presence of lymphopenia is ac-
companied by other changes in laboratory parameters such
as hypoalbuminemia and elevated levels of serum creati-
nine as well as need for higher inotrope dose preopera-
tively and the presence of genetic/congenital anomaly.
Thus, preoperative lymphopenia should be considered as
a sign of underlying illness that could be a result of in-
creased lymphocyte destruction such as is seen in systemic
inflammatory response syndrome, decreased lymphocyte
production as seen in DiGeorge syndrome, or due to in-
creased loss from lymphatic dysplasia as seen in Noonan
syndrome. We propose the addition of lymphopenia to
the existing preoperative strategies for risk assessment
and stratification.1178 The Journal of Thoracic and Cardiovascular SReferences
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